Yestle Kim

9PUBLICATIONS
27CO-AUTHORS
Disease surveillanceMetabolic medicineCardiology (incl. cardiovascular diseases)Major global burdens of diseaseNutritional science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 08, 2026
Risk of Extrahepatic Cancer for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the United States Medicare Population.

Yestle Kim, Dominic Nunag, Matthew Davis

|Oct 06, 2025
Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitis.

Elliot B Tapper, Taylor Ryan, Ni Zeng

|Jul 16, 2025
Metabolic Dysfunction-Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus Panel.

Yestle Kim, Peter Rydqvist, Thomas Ramezani

|Jun 11, 2025
Cardiovascular Risk Assessment Tools are Insufficient for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.

A Sidney Barritt, Elliot B Tapper, Philip N Newsome

|Apr 23, 2025
Estimating the clinical and healthcare burden of metabolic dysfunction-associated steatohepatitis in England: a retrospective cohort study using routinely collected healthcare data from 2011 to 2020.

Jennifer A Davidson, Hannah R Brewer, Caoimhe T Rice

|Nov 22, 2024
Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study.

Yestle Kim, Joseph Medicis, Matthew Davis

Pageof 2

Frequent Collaborators

2 joint publications

Matthew Davis

2 joint publications

Robert Gish

1 joint publications

Jesse Fishman

1 joint publications

Hélène Parisé